IL4R rs1805015: What Your Genotype Means
The rs1805015 polymorphism is a common missense variant in the interleukin-4 receptor alpha (IL4R) gene, classically designated as I50V. This variant alters the receptor's extracellular domain and has been widely investigated for its role in modulating immune signaling pathways. Across biomedical literature, it shows modest statistical associations with allergic conditions, atopy, and asthma susceptibility, though overall clinical evidence remains limited and context-dependent.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| TT | Carriers of the TT genotype possess two copies of the baseline thymine allele encoding isoleucine at position 50. This genotype reflects standard baseline IL-4 receptor sensitivity and has been used as the reference comparator in classical association studies. It is not associated with elevated genetic predisposition to enhanced Th2 pathway activation. | Informational |
| CT | Individuals with the CT heterozygous genotype carry one reference allele and one missense-associated cytosine allele. Studies observe intermediate downstream signaling characteristics in laboratory models, with modest or negligible shifts in statistical susceptibility to atopy. It represents an extremely common genotype found in general populations worldwide. | Informational |
| CC | Carriers of two cytosine alleles produce receptor subunits carrying valine at codon 50, which research models associate with enhanced downstream STAT6 activation in response to IL-4. Epidemiological studies note small statistical correlations with elevated allergic susceptibility or IgE levels in certain cohorts, though effect sizes remain subtle and multifactorial. This result does not establish an allergy diagnosis. | Higher attention |
Variant Identity and Molecular Location
The single nucleotide polymorphism rs1805015 resides on chromosome 16 within the IL4R gene, which encodes the alpha subunit of the interleukin-4 receptor. At the molecular level, this transition variant involves a thymine-to-cytosine switch (c.148A>G depending on transcript orientation and strand annotation), resulting in an isoleucine-to-valine substitution at codon 50, frequently referred to in immunogenetics as the I50V change. Codon 50 is situated within the extracellular cytokine-binding region of the receptor. Because it lies near the binding interface, alterations at this position can subtly influence how the receptor interacts with its signaling partners. Identified in global databases such as dbSNP and ClinVar, rs1805015 is categorized as a common, naturally occurring human genetic polymorphism rather than a high-penetrance monogenic mutation.
The Biological Role of the IL4R Gene
The IL4R gene provides instructions for building the interleukin-4 receptor alpha (IL-4Rα) chain, an indispensable hub in human immune signaling. This receptor chain is shared between two distinct heterodimeric complexes: the Type I receptor (activated by interleukin-4) and the Type II receptor (responsive to both interleukin-4 and interleukin-13). When activated, IL-4Rα drives downstream phosphorylation through the JAK-STAT pathway, predominantly activating STAT6. This cascade directs the differentiation of naive helper T cells into Th2 effector cells, stimulates B cells to switch antibody classes toward immunoglobulin E (IgE), and regulates eosinophil recruitment. Consequently, subtle changes in IL-4Rα signaling can alter the baseline sensitivity of the immune system to environmental antigens, allergens, and parasitic pathogens.
Research Associations and Evidence Strength
Decades of candidate-gene investigations and epidemiological cohorts have explored rs1805015 for potential links to allergic rhinitis, atopic dermatitis (eczema), elevated total serum IgE, and childhood asthma. Functional biochemical assays suggest that the variant receptor chain may enhance downstream STAT6 phosphorylation and responsiveness to IL-4. However, large genome-wide association studies (GWAS) and meta-analyses provide a more tempered view: the clinical evidence strength is characterized as limited. While some populations exhibit modest statistical correlations between specific alleles and atopic phenotypes, effect sizes across diverse cohorts are small and frequently show mixed reproducibility. Because allergic conditions are polygenic and heavily driven by environmental exposures, carriage of this variant explains only a minor portion of overall allergic liability.
Population Distribution and Ancestry Patterns
Unlike rare pathogenic mutations, rs1805015 is an ancient, highly prevalent human polymorphism. Data from large-scale reference datasets such as the Genome Aggregation Database (gnomAD) indicate that the minor allele frequency ranges between approximately 0.35 and 0.50 across major continental ancestries. Because the alternate allele is widespread in European, African, East Asian, South Asian, and Latino populations, both homozygous and heterozygous genotypes are routinely observed in healthy individuals worldwide. The high global frequency of this variant underscores that it is a normal element of human immunological diversity rather than a rare disruptor of gene function, reflecting evolutionary pressures on pathogen response and immune homeostasis.
Practical Interpretation and Everyday Health
Understanding your rs1805015 genotype provides an educational glimpse into your immune-signaling architecture, but it has important practical limitations. A personal genetic report showing one or two copies of a variant allele does not diagnose allergic disease, asthma, or atopic dermatitis, nor does it guarantee you will develop allergic symptoms. Conversely, harboring common baseline alleles does not prevent allergies from occurring. Commercial genetic profiling for candidate SNPs like rs1805015 cannot replace clinical evaluation by a medical provider. Readers with persistent symptoms of respiratory allergies, atopic skin disease, or wheezing should seek guidance from a physician or allergist, who diagnose conditions based on symptoms, physical exams, and standardized diagnostic testing.
How common is this variant?
The minor allele frequency for rs1805015 ranges between approximately 0.35 and 0.50 across major global ancestry groups in gnomAD. Because both alleles are exceptionally common worldwide, heterozygous and homozygous genotypes are routinely seen across all continental populations.
Frequently asked questions
Does carrying the rs1805015 variant mean I will get asthma or eczema?
No. The rs1805015 variant is an extremely common polymorphism that confers only a modest statistical association with immune traits in select population studies. Atopy and asthma are complex conditions shaped by hundreds of genetic variants alongside environmental factors, allergen exposures, and lifestyle elements.
What is the biological difference between the I50 and V50 forms of IL4R?
The rs1805015 SNP changes the 50th amino acid in the receptor from isoleucine (I50) to valine (V50). In cellular laboratory assays, the V50 form has shown slightly heightened sensitivity to IL-4 binding, leading to mildly enhanced downstream signaling via the STAT6 pathway.
Can testing rs1805015 help choose my allergy or asthma medication?
Current clinical pharmacogenomic guidelines from bodies such as CPIC and the FDA do not provide genotype-based dosing or selection recommendations for rs1805015. Any decisions regarding asthma medications, biologics, or allergy treatments should always be guided by an evaluating physician.
Why is the evidence strength for rs1805015 rated as limited?
While early candidate-gene studies linked rs1805015 with atopy, subsequent large-scale genome-wide association studies (GWAS) demonstrated that its individual contribution to overall allergic risk is modest and varies across different ancestral backgrounds. Its clinical utility for individual risk prediction remains unsupported.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1805015?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29